ライフサイエンスコーパス: grip strength

1 , were taller, more muscular, and had higher grip strength.

2 ysial collagen III deposition, and hind limb grip strength.

3 ociation was attenuated after adjustment for grip strength.

4 uch as elevated pain sensitivity and reduced grip strength.

5 dismutase in spinal motor neurons preserved grip strength.

6 These findings were not explained by grip strength.

7 was generally associated only with increased grip strength.

8 ysmetria and dysdiadochokinesia but not with grip strength.

9 ation, speech and swallowing assessments and grip strength.

10 that was 30 percent of the maximal voluntary grip strength.

11 dent OA at different hand joints and maximal grip strength.

12 trically measured flexed arm muscle mass and grip strength.

13 tion of fibrosis and restoration of forelimb grip strength.

14 were more robust for walking speed than for grip strength.

15 uding robust hind limb elements modified for grip strength.

16 , mechanical hypersensitivity, and decreased grip strength.

17 paired motor control, exercise capacity, and grip strength.

18 tands, 1.9 for standing balance, and 1.7 for grip strength.

19 -m walk, chair stands, standing balance) and grip strength.

20 in, hair, and eye color, blood pressure, and grip strength.

21 .52, p = .001) and left (r = 0.50, p = .002) grip strength.

22 er 3 months on the waiting list: -0.38 kg in grip strength, -0.05 meters/second in gait, 0.03 seconds

23 weight-supported hanging (43% increase) and grip strength (25% increase), were obtained after hypoth

24 he WMFT (-1.39 kg, -2.74 to -0.04), for WMFT grip strength (-4.39 kg, -6.91 to -1.86), for amount of

25 0.26 kg, P < 0.001; 11 studies, n = 308) and grip strength (5.3%, P < 0.050; 4 studies, n = 156), whi

26 ed swollen and tender joint count and score, grip strength, 50-foot walking time, duration of morning

27 e we examine the morphological correlates of grip strength, a defensive combat trait involved in mate

28 ivation of the Col12a1 gene showed decreased grip strength, a delay in fiber-type transition and a de

29 We also collected lung capacity, grip strength, a series of balance tests, and a timed wa

30 5% confidence interval: 1.04, 6.84), and low grip strength (adjusted odds ratio = 3.29, 95% confidenc

31 led paw reaching after correct repair and in grip strength after crossover repair.

32 ge, sex, race, cognition, comorbidities, and grip strength, AMD subjects showed an increased likeliho

33 ons of radiographic variables with pinch and grip strength among individuals with radiographic hand O

34 sed risk (95% CI, 1%-23%) of developing weak grip strength and a 14% decreased risk (95% CI, 8%-20%)

35 ulted in significant improvement in hindlimb grip strength and a 30% decrease in inflammation in the

36 idisciplinary expert team measured patients' grip strength and assessed their predicted mobilization

37 High grip strength and avoidance of overweight, hyperglycemia

38 ligible patients had low performance on hand grip strength and chair rise tests, tested with the proc

39 decline in normalized forelimb and hindlimb grip strength and declines in in vitro EDL force after r

40 observed for cardiovascular mortality.Lower grip strength and excess adiposity are both independent

41 d osteoarthritis and to assess its impact on grip strength and functional activities.

42 th performance; those in the lowest fifth of grip strength and highest fifth of BMI having particular

43 No association was found between maximal grip strength and incident OA in the DIP joints of men o

44 ease onset, weight loss, decline in hindlimb grip strength and increased animal survival.

45 ured using dual energy x-ray absorptiometry; grip strength and information on lifestyle indicators, i

46 was significantly associated with both lower grip strength and lower pinch strength.

47 Grip strength and manual dexterity were not changed by r

48 In fact, grip strength and maximum isometric tetanic force are ev

49 ansplantation levels on all tests except for grip strength and motor dexterity.

50 Grip strength and observed functional performance were e

51 from 5.0 to 2.9 mm; P = .02), but changes in grip strength and pain were not significant for control

52 function was assessed by measuring pinch and grip strength and peripheral vibration thresholds.

53 havioral (Digiscan) and functional outcomes (grip strength and Rotarod) were assessed prior to sacrif

54 function, assessed by skilled paw reaching, grip strength and sensory testing varied with accuracy o

55 to reduce the likelihood of developing weak grip strength and slow walking speed because purpose has

56 ssociated with lower risk of developing weak grip strength and slow walking speed over time.

57 ted with a decreased risk of developing weak grip strength and slow walking speed, although the findi

58 nsight into the mechanistic underpinnings of grip strength and the causal role of muscular strength i

59 pressure and attenuation of decline in both grip strength and time to death.

60 with a control group differed on functional (grip strength and walk time) and disease activity (total

61 rove locomotive function as well as forelimb gripping strength and coordination.

62 score, a 1.12-kg (95% CI: 0.83, 1.40) lower grip strength, and a 4.7-nm (95% CI: 3.5, 5.9) lower kne

63 ts in dystonic movements, motor performance, grip strength, and body weight that progressively worsen

64 nce score (sum of quartiles of walking pace, grip strength, and chair-stand speed; range, 0-9) were a

65 basic behavioral activities, impaired muscle grip strength, and defects in motor coordination.

66 ositive effects of exercise on walk time and grip strength, and demonstrated that fatigue and perceiv

67 Pain score, grip strength, and dexterity were measured before surger

68 hy Impairment Score of the Lower Limbs, hand grip strength, and evaluation of vegetative dysfunction,

69 strength, measured by hindlimb and forelimb grip strength, and heat nociception, measured by tail-fl

70 Treadmill exercise capacity, forelimb grip strength, and in vivo maximum tetanic force were al

71 -min walking distance, fast gait speed, hand grip strength, and isometric leg extension strength).

72 with transient increases in weight, forelimb grip strength, and myofiber size.

73 ipants were stratified by country, age, hand grip strength, and performance on the chair rise test, a

74 oss, exhaustion, low walking speed, low hand grip strength, and physical inactivity.

75 defects such as hind limb clenching, reduced grip strength, and reduced locomotor activity.

76 ere the number of tender and swollen joints, grip strength, and the erythrocyte sedimentation rate (E

77 FE65 family KO mice show attenuated grip strength, and the nuclei of DKO muscle cells freque

78 l class, as well as with the amount of pain, grip strength, and walking velocity.

79 Men with high maximal grip strength are at increased risk for the development

80 The risk of developing weak grip strength (assessed as a binary yes or no outcome) o

81 After twenty-four hours, grip strength assessment revealed that Daf1(-/-) mice ex

82 otor functions, including breathing pattern, grip strength, balance beam and rotarod performance.

83 treated mice exhibited improved body weight, grip strength, bone integrity, and percent survival at 2

84 icantly increased body weight, lean mass and grip strength by 60-80% over vehicle-treated mdx mice.

85 edly administered to effectively reduce hand-grip strength by approximately 50 % of control.

86 The final frailty index consisted of: grip strength, chair stands, and balance.

87 r adults in the home, body mass index (BMI), grip strength, cognitive ability, mood, or comorbid illn

88 demonstrated improved downward climbing and grip strength compared with those given vehicle, though

89 statistically significant (14 days) delay in grip strength decline but not in the onset of paralysis,

90 Grip strength did not change in either group.

91 Grip strength did not differ between the groups.

92 9; 95% CI, 0.83-0.95), but associations with grip strength did not reach conventional levels of stati

93 The effects of birth weight on grip strength did not vary by childhood or current body

94 ty 25 years later increased as baseline hand grip strength, divided into tertiles, declined.

95 stimulation, and behavioural tests including grip strength, double simultaneous stimulation and joint

96 ound; African-American HRT users had greater grip strength during the study, whereas Caucasian HRT us

97 walk, 5 chair stands, standing balance, and grip strength, each scored from 0 to 4 (0, unable to per

98 but other measurements of strength (forelimb grip strength, ex vivo measurements of contractile funct

99 ds ratio = 2.43; 95% CI, 1.17-5.03) and poor grip strength, exhaustion, and slowed walking speed (haz

100 Slow walking speed, low grip strength, exhaustion, low physical activity, and un

101 Both BMI and grip strength exhibited non-linear relations with perfor

102 he 5 secondary criteria, and 3) substituting grip strength for HAQ scores.

103 /p+) and Ube3a(m-/p-) mice in rope climbing, grip strength, gait and a raised-beam task.

104 ailty was measured on a scale from 0 to 5 by grip strength, gait speed, exhaustion, shrinkage, and ph

105 Higher grip strength (GS) is associated with lower mortality ri

106 Men with greater leg power and grip strength had significantly reduced fall risk (for h

107 (HDL) cholesterol, forced expiratory volume, grip strength, HbA1c, longevity, obesity, self-rated hea

108 he last year were inversely related to adult grip strength, height, and walking speed in men and wome

109 mmonia, increase in lean body mass, improved grip strength, higher skeletal muscle mass and diameter,

110 .21; 95% CI: 1.32, 3.71) and/or reduced hand grip strength (HR: 1.53; 95% CI: 10.07, 2.17) than in th

111 complex to calcium improves muscle force and grip strength immediately after administration of single

112 d the relation between birth weight and hand grip strength in a prospective national birth cohort of

113 mouse or change gait, motor coordination, or grip strength in adult mice of both sexes.

114 s total intake, anthropometric measures, and grip strength in COPD.

115 brosis, and significantly improved hind limb grip strength in mdx mice.

116 Higher BMI was associated with stronger grip strength in men only.

117 TCS acutely depresses hemodynamics and grip strength in mice at doses >/=12.5 mg/kg i.p., and a

118 proving intake, anthropometric measures, and grip strength in stable COPD.

119 baseline to endpoint were also recorded for grip strength in the dominant hand (treatment difference

120 e yoga groups had significant improvement in grip strength (increased from 162 to 187 mm Hg; P = .009

121 Hand grip strength is a widely used proxy of muscular fitness

122 e rates are higher when the HAQ, rather than grip strength, is used to measure physical function.

123 nce intervals -16.786 to -4.482) decrease in grip strength (kg force) (P < 0.001) and -8.74 (95% conf

124 Truncal flexion and extension strength, hand grip strength, leg extension power, and quality of life

125 The most common pattern was poor grip strength, low physical activity, and slowed walk sp

126 >/=30) in the lowest tertile of sex-specific grip strength (<35.3 kg for men and <19.6 kg for women).

127 ic knee extension, plantar flexion, and hand grip strength measures.

128 articipants viewing TV >/= 6 hrs/d had lower grip strength (Men, B = -1.20 kg, 95% CI, -2.26, -0.14;

129 ast, internet use was associated with higher grip strength (Men, B = 2.43 kg, 95% CI, 1.74, 3.12; Wom

130 ded hindlimb and forelimb muscle strength by Grip Strength Meter and quantitative muscle fibrosis par

131 onal deficits were tested on the rotarod and grip-strength meter at 24, 48 and 72 h after pMCAO.

132 No significant changes in flexion or grip strength, no systemic allergic reactions, and no ne

133 Only 7.8% of paired grip strength observations showed > or =20% improvement,

134 ain on an accelerating rotarod and increased grip strength observed in the pMCAO rats treated with PR

135 t 10 IU/day (but not at 1 IU/day), increased grip strength of the contralesional paretic forelimb and

136 ausal effect of higher genetically predicted grip strength on lower fracture risk.

137 9 months of age, whereas, losartan improved grip strength only at 2 months.

138 icting disability reduced the ORs related to grip strength only minimally.

139 No significant changes occurred in grip strength or dexterity from preoperative baseline to

140 were seen between the groups in knee or hand grip strength or in systemic endurance.

141 ere was no significant change of either hand grip strength or leg extension power.

142 , fixed-speed rotarod, accelerating rotarod, grip strength, or loss of righting reflex tests.

143 ght changes, lifespan, RotaRod performances, grip strength, overall activity and no significant effec

144 ant impairments of joint range of motion and grip strength (P < .001).

145 Participants with CMT2A had the weakest grip strength (P < .05), while those with CMT2A and CMT4

146 The only ray significantly associated with grip strength (P < 0.05) was ray 1, and no individual ra

147 (P = .03) and B (P = .05), right-sided Jamar grip strength (P = .02), Rapid Pace Walk (P = .03), Brak

148 te perimenopause showed a 0.93-kg decline in grip strength (p = 0.07).

149 e postmenopausal showed a 1.04-kg decline in grip strength (p = 0.10) and a 0.57-kg decline in pinch

150 viduals and identify 16 loci associated with grip strength (P<5 x 10(-8)) in combined analyses.

151 of the erythrocyte sedimentation rate (ESR), grip strength, pain scores, tender joint counts, and anx

152 For example, greater grip strength (per 6 kg) had an odds ratio (95% CI) of 0

153 -appearing brain was associated with: weaker grip strength, poorer lung function, slower walking spee

154 ll Pain Questionnaire Short Form, walk time, grip strength, predicted maximum oxygen uptake, and join

155 risk = 0.82, 95% CI: 0.73, 0.92; for highest grip strength quartile vs. lowest: relative risk = 0.76,

156 isease duration (r = 0.51 for each measure), grip strength (r = -0.49 for NDJ, and r = -0.51 for Shar

157 the risk of all-cause mortality increased as grip strength reduced within each BMI category.

158 tive relation between birth weight and adult grip strength remained after adjustment first for adult

159 Both BMI and grip strength remained independently related with perfor

160 cts with the disease had 10% reduced maximal grip strength, reported more difficulty writing, handlin

161 In multivariate models, the mean ESR, mean grip strength, rheumatoid factor positivity, and tender

162 monstrated significant motor deficits (e.g., grip strength, righting reflex and touch escape) in bf m

163 Frailty was measured by 4-m walk time, grip strength, self-reported weight loss, exhaustion, an

164 ent (beam walking, pole climbing, wire hang, grip strength), sensorimotor skills (rotarod), mechanica

165 3 weeks after stroke on locomotor activity, grip strength, sensory neglect, gait impairment, motor c

166 ced vital capacity, resting heart rate, hand grip strength, sit and reach distance, and time standing

167 or more of the following 5 components: weak grip strength, slowed walking speed, poor appetite, phys

168 ss index (Spearman r=0.28, P<0.0001), weaker grip strength (Spearman r=-0.34, P<0.01), and slower wal

169 Ab levels were significantly correlated with grip strength (Spearman r=-0.57, P<0.005), walking speed

170 ures of physical capability at age 53 years: grip strength, standing balance, and chair-rise time.

171 , and occupational category using the lowest grip strength tertile as the referent.

172 2 times greater in the lowest vs the highest grip strength tertile.

173 ced skeletal muscle function, as measured by grip strength tests 4 weeks after injection.

174 in mdx mice as demonstrated through in vivo grip strength tests and in vitro contraction measurement

175 ysfunction as determined by both rotorod and grip strength tests, as well as enhanced loss of motor n

176 .03), appendicular skeletal muscle mass, and grip strength than did controls, but these differences w

177 rthermore, mdx3cv mice had stronger forelimb grip strength than mdx4cv mice.

178 ted more strongly with exercise capacity and grip strength than with lung function.

179 for the functional measures of walk time and grip strength: the treatment groups improved more than t

180 ms and four measures of physical capability: grip strength, timed walk or get up and go, chair rises

181 5 and 0.025, respectively) but not with hand-grip strength, triceps skin-fold thickness (TSFT), or mi

182 coordination with the finger-nose test, and grip strength using the Jamar dynamometer.

183 Patients were clinically assessed on grip strength, vibration perception thresholds and postu

184 nd changes in the rate of decline of leg and grip strength, vital capacity, ALS Functional Rating Sca

185 9 (95% CI, 1.14-2.81) in the middle third of grip strength vs those in the highest third.

186 n; joint tenderness, swelling, or deformity; grip strength; walking velocity; and timed button test.

187 urrent work status; vital status at 6 years; grip strength; walking velocity; the timed-button test;

188 Grip strength was assessed using Smedley spring-type han

189 In men, higher maximal grip strength was associated with an increased risk of O

190 Stronger grip strength was associated with better performance on

191 A significant HRT-by-race interaction for grip strength was found; African-American HRT users had

192 Among healthy 45- to 68-year-old men, hand grip strength was highly predictive of functional limita

193 Additionally, forelimb grip strength was improved after 1D11 treatment at both

194 Grip strength was improved significantly for both hands

195 e healthy at baseline and whose maximal hand grip strength was measured from 1965 through 1970.

196 Grip strength was measured in kilograms by dynamometer i

197 We found that grip strength was repeatable and differed between the se

198 ly joint group significantly associated with grip strength was the CMCs, and only OA in the MCP joint

199 Grip strength was used as a marker of sarcopenia.

200 ate the genetic determinants of variation in grip strength, we perform a large-scale genetic discover

201 d motor coordination impairments and reduced grip strength were detected in En2 null mutants.

202 Unadjusted LBM and grip strength were similar in 2 groups.

203 cle alone but to be insufficient to maintain grip strength, whereas delivery to both motor neurons an

204 erformance was assessed by walking speed and grip strength, while global functional limitation, acros

205 , 2.17) than in those with stable weight and grip strength, with the highest risk in those with both